By down-regulating the TLR, suppress the activation of NF-κB and block the signal from being sent to the downstream factor TNF-α, in order to resist immune cell infiltration and relieve ischemic stroke (Lu et al., 2025; Hao et al., 2023). The gene discussed is TNF; the disease is ischemic stroke.